Mechanistically, we identified that tRF-Val directly bound to the chaperone molecule EEF1A1, mediated its transport into the nucleus, and promoted its interaction with MDM2 (a specific p53 E3 ubiquitin ligase), thus inhibiting the downstream molecular pathway of p53 and promoting GC progression. The gene discussed is TP53; the disease is gastric cancer.